Kala Research Development from 2010 to 2026
| KALA Stock | USD 0.40 0.01 2.44% |
Research Development | First Reported 2015-12-31 | Previous Quarter 6.2 M | Current Value 6.1 M | Quarterly Volatility 1.7 M |
Check Kala Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kala Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4 M, Interest Expense of 4.7 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 16.28, Dividend Yield of 0.0 or PTB Ratio of 3.39. Kala financial statements analysis is a perfect complement when working with Kala Pharmaceuticals Valuation or Volatility modules.
Kala | Research Development | Build AI portfolio with Kala Stock |
Analyzing Kala Pharmaceuticals's Research Development over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Research Development has evolved provides context for assessing Kala Pharmaceuticals's current valuation and future prospects.
Latest Kala Pharmaceuticals' Research Development Growth Pattern
Below is the plot of the Research Development of Kala Pharmaceuticals over the last few years. It is Kala Pharmaceuticals' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kala Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Kala Research Development Regression Statistics
| Arithmetic Mean | 17,743,137 | |
| Geometric Mean | 15,918,837 | |
| Coefficient Of Variation | 44.34 | |
| Mean Deviation | 6,658,835 | |
| Median | 18,352,000 | |
| Standard Deviation | 7,867,185 | |
| Sample Variance | 61.9T | |
| Range | 21.6M | |
| R-Value | 0.59 | |
| Mean Square Error | 43.3T | |
| R-Squared | 0.34 | |
| Significance | 0.01 | |
| Slope | 913,540 | |
| Total Sum of Squares | 990.3T |
Kala Research Development History
About Kala Pharmaceuticals Financial Statements
Kala Pharmaceuticals stakeholders use historical fundamental indicators, such as Kala Pharmaceuticals' Research Development, to determine how well the company is positioned to perform in the future. Although Kala Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Kala Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Kala Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Kala Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 25.4 M | 21.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Kala Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kala Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kala Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kala Pharmaceuticals Stock:Check out the analysis of Kala Pharmaceuticals Correlation against competitors. For information on how to trade Kala Stock refer to our How to Trade Kala Stock guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kala Pharmaceuticals. Expected growth trajectory for Kala significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Kala Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Kala Pharmaceuticals is measured differently than its book value, which is the value of Kala that is recorded on the company's balance sheet. Investors also form their own opinion of Kala Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kala Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kala Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kala Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Kala Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Kala Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Kala Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.